Fortrea (FTRE) Competitors $20.27 +0.82 (+4.22%) (As of 12/12/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FTRE vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, and PRVAShould you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Fortrea vs. Hims & Hers Health Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Hims & Hers Health (NYSE:HIMS) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking. Which has preferable earnings and valuation, HIMS or FTRE? Fortrea has higher revenue and earnings than Hims & Hers Health. Fortrea is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.24B5.29-$23.55M$0.4468.41Fortrea$3.11B0.58-$3.40M-$3.42-5.93 Do analysts rate HIMS or FTRE? Hims & Hers Health currently has a consensus price target of $21.43, suggesting a potential downside of 28.81%. Fortrea has a consensus price target of $23.30, suggesting a potential upside of 14.95%. Given Fortrea's higher probable upside, analysts clearly believe Fortrea is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.38Fortrea 1 Sell rating(s) 11 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.92 Does the media prefer HIMS or FTRE? In the previous week, Fortrea had 4 more articles in the media than Hims & Hers Health. MarketBeat recorded 18 mentions for Fortrea and 14 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.90 beat Fortrea's score of 0.21 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 9 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, HIMS or FTRE? Hims & Hers Health has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Does the MarketBeat Community prefer HIMS or FTRE? Hims & Hers Health received 27 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 38.00% of users gave Hims & Hers Health an outperform vote while only 25.58% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3838.00% Underperform Votes6262.00% FortreaOutperform Votes1125.58% Underperform Votes3274.42% Is HIMS or FTRE more profitable? Hims & Hers Health has a net margin of 8.19% compared to Fortrea's net margin of -10.99%. Hims & Hers Health's return on equity of 10.97% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Fortrea -10.99%2.00%0.80% Do insiders & institutionals believe in HIMS or FTRE? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 0.1% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryHims & Hers Health beats Fortrea on 14 of the 18 factors compared between the two stocks. Ad ProsperityPubFree Cheat Sheet: Build a Dividend PortfolioHave you ever wanted to build your own, custom dividend portfolio? A well-rounded portfolio of high quality dividend stocks that produce passive cash flow is one of the best ways to build your nest egg. And, according to one expert, you can do it with a very straightforward process too!These FIVE (FREE) Dividend Investing Cheatsheets Show you How! Get Fortrea News Delivered to You Automatically Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTRE vs. The Competition Export to ExcelMetricFortreaMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.82B$2.94B$5.09B$9.20BDividend YieldN/A10.83%5.18%3.95%P/E Ratio-5.9316.75105.5217.56Price / Sales0.58263.091,311.86126.74Price / Cash8.71468.7235.9135.66Price / Book1.045.164.874.89Net Income-$3.40M-$32.86M$115.25M$224.92M7 Day Performance-14.00%-1.61%-0.23%0.21%1 Month Performance-7.65%6.75%-2.10%3.67%1 Year Performance-36.28%22.00%31.94%27.21% Fortrea Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTREFortrea2.4506 of 5 stars$20.27+4.2%$23.30+14.9%-36.3%$1.74B$2.98B-5.9318,000Analyst DowngradeHIMSHims & Hers Health3.7603 of 5 stars$33.14-3.2%$21.43-35.3%+257.1%$7.24B$872M75.051,046Insider TradeShort Interest ↑GHGuardant Health3.9427 of 5 stars$36.28-1.6%$40.60+11.9%+30.4%$4.48B$692.26M-8.561,779Positive NewsOPCHOption Care Health4.8964 of 5 stars$23.16+1.4%$30.14+30.2%-23.5%$3.94B$4.30B19.467,802Short Interest ↑Positive NewsSHCSotera Health3.8921 of 5 stars$13.42+2.2%$16.08+19.8%-7.3%$3.80B$1.05B53.923,000Positive NewsVCYTVeracyte4.0797 of 5 stars$42.72-3.2%$41.13-3.7%+73.7%$3.31B$361.05M0.00790News CoverageBTSGBrightSpring Health Services2.2507 of 5 stars$17.81-2.6%$17.21-3.4%N/A$3.10B$8.83B0.0035,000Analyst ForecastNews CoveragePositive NewsLFSTLifeStance Health Group1.9232 of 5 stars$7.41+1.0%$8.50+14.7%+6.6%$2.84B$1.06B0.009,325Positive NewsSGRYSurgery Partners3.4982 of 5 stars$22.28+1.8%$37.38+67.8%-37.8%$2.83B$2.74B0.0013,500CONConcentra Group Holdings ParentN/A$20.61+1.7%$28.50+38.3%N/A$2.62B$1.84B0.0011,000PRVAPrivia Health Group2.5904 of 5 stars$21.56+1.8%$24.79+15.0%-4.9%$2.59B$1.66B211.821,102Positive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors CON Competitors PRVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FTRE) was last updated on 12/13/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTRE Stock Alerts